Which medications can be given to a patient with vertigo and how many rest days should be indicated on a medical certificate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Medication and Rest Days for Vertigo

For acute vertigo, prescribe vestibular suppressants (meclizine 25mg TID, dimenhydrinate 50mg TID, or diazepam 2-5mg TID) for SHORT-TERM use only (3-5 days maximum), and provide 3-7 days of rest depending on the underlying cause and severity of symptoms.

Medication Selection

The choice of medication depends entirely on identifying the specific cause of vertigo, as treatment differs dramatically between conditions 1, 2:

For Acute Vestibular Conditions (Vestibular Neuritis/Labyrinthitis)

  • Vestibular suppressants are appropriate ONLY during the acute phase 2
  • Options include:
    • Benzodiazepines (diazepam 2-5mg TID or lorazepam 0.5-1mg TID)
    • Antihistamines (meclizine 25mg TID or dimenhydrinate 50mg TID)
    • Anticholinergics (scopolamine patch)
  • Critical caveat: Use for 3-5 days MAXIMUM, as prolonged use delays vestibular compensation and worsens long-term outcomes 3, 4

For BPPV (Brief Positional Vertigo <1 minute)

  • NO medications recommended 1, 5
  • Treatment is the Epley maneuver (canalith repositioning)
  • Vestibular suppressants only for severe nausea/vomiting during the procedure 6
  • This is the MOST COMMON cause of vertigo (42% of cases) 1

For Ménière's Disease (Hours-long attacks with hearing loss/tinnitus)

  • Acute attacks: Vestibular suppressants for symptom control during attacks only 2
  • Prevention: Betahistine 48mg TID (high dose required) 7, 8
  • Salt restriction and diuretics for long-term management 4

For Vestibular Migraine (Hours-long attacks, migraine history)

  • Acute: Vestibular suppressants for severe episodes
  • Prevention: Beta-blockers (metoprolol), calcium channel blockers (flunarizine), or topiramate 3, 9
  • CGRP-targeted therapies (erenumab, fremanezumab) show promise for refractory cases 10

Critical Diagnostic Distinctions

Before prescribing, determine the timing pattern 1:

  • Seconds: BPPV → No medications, do Epley maneuver
  • Minutes to hours: Ménière's or vestibular migraine → Preventive therapy
  • Days (12-36 hours): Vestibular neuritis → Short-term suppressants + consider corticosteroids 2
  • Positional trigger: BPPV
  • Spontaneous: Vestibular neuritis, Ménière's, migraine

Red flags requiring immediate referral (NOT simple vertigo): Stroke symptoms (dysarthria, dysphagia, visual changes, neurologic deficits), severe headache, or vertigo lasting >24 hours with neurologic signs 2

Rest Days Recommendation

BPPV

  • 1-3 days if Epley maneuver successful
  • Patients can return to normal activity once symptoms resolve
  • No benefit to prolonged rest 5

Vestibular Neuritis

  • 5-7 days for acute phase
  • Severe rotational vertigo lasts 12-36 hours, with decreasing symptoms over 4-5 days 2
  • Early mobilization after initial 2-3 days promotes compensation

Ménière's Disease (Acute Attack)

  • 3-5 days per attack
  • Variable based on attack severity and recovery

Vestibular Migraine

  • 3-5 days for severe attacks
  • Return to work when vertigo and associated symptoms resolve

Common Pitfalls to Avoid

  1. Prolonged vestibular suppressant use: Beyond 5 days delays central compensation and prolongs disability 3, 4
  2. Prescribing medications for BPPV: Wastes time and money; perform Epley maneuver instead 1, 6, 5
  3. Missing stroke: Always assess for central signs (dysarthria, diplopia, ataxia beyond what vertigo explains) 2
  4. Inadequate betahistine dosing: If using for Ménière's, must use ≥48mg TID; lower doses ineffective 7, 8
  5. Not considering benzodiazepine dependence: All benzodiazepines carry significant addiction risk with prolonged use 2

References

Guideline

clinical practice guideline: benign paroxysmal positional vertigo (update).

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2017

Guideline

clinical practice guideline: ménière's disease.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2020

Research

Which medication do I need to manage dizzy patients?

Acta oto-laryngologica, 2011

Research

[Pharmacotherapy of Vestibular Disorders, Nystagmus and Cerebellar Disorders].

Fortschritte der Neurologie-Psychiatrie, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.